554 related articles for article (PubMed ID: 19258831)
1. Novel pathway for sudden cardiac death prevention.
Herzog E; Aziz EF; Kukin M; Steinberg JS; Mittal S
Crit Pathw Cardiol; 2009 Mar; 8(1):1-6. PubMed ID: 19258831
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
Finch NJ; Leman RB
Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
[TBL] [Abstract][Full Text] [Related]
4. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation.
Botto GL; Proclemer A; Luzi M; Ruffa F; Gorgoglione MG; Ferrari G
Ital Heart J; 2005 Mar; 6(3):210-5. PubMed ID: 15875511
[TBL] [Abstract][Full Text] [Related]
5. [Risk stratification for sudden cardiac death: should we juist consider ejection fraction?].
Paolucci M; Cattafi G; Magenta G; Vecchi MR; Schirru M; Lunati M
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):27S-32S. PubMed ID: 19195303
[TBL] [Abstract][Full Text] [Related]
6. Sudden death prophylaxis in heart failure.
Rosanio S; Schwarz ER; Vitarelli A; Zarraga IG; Kunapuli S; Ware DL; Birnbaum Y; Tuero E; Uretsky BF
Int J Cardiol; 2007 Jul; 119(3):291-6. PubMed ID: 17208319
[TBL] [Abstract][Full Text] [Related]
7. Risk stratification applied to CAST registry data: combining 9 predictors. Cardiac Arrhythmia Suppression Trial.
Church TR; Hodges M; Bailey JJ; Mongin SJ
J Electrocardiol; 2002; 35 Suppl():117-22. PubMed ID: 12539108
[TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: implications of international guidelines.
Foley PW; Addison CE; Whinney SB; Patel K; Cunningham D; Frenneaux MP; Leyva F
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S131-4. PubMed ID: 19250076
[TBL] [Abstract][Full Text] [Related]
9. [Risk stratification and prevention of sudden death in patients with heart failure].
Villacastín J; Bover R; Castellano NP; Moreno J; Morales R; García-Espinosa A
Rev Esp Cardiol; 2004 Aug; 57(8):768-82. PubMed ID: 15282066
[TBL] [Abstract][Full Text] [Related]
10. Sudden cardiac death.
Antezano ES; Hong M
J Intensive Care Med; 2003; 18(6):313-29. PubMed ID: 14984660
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular ejection fraction for the risk stratification of sudden cardiac death: friend or foe?
Santangeli P; Dello Russo A; Casella M; Pelargonio G; Di Biase L; Natale A
Intern Med J; 2011 Jan; 41(1a):55-60. PubMed ID: 21265961
[TBL] [Abstract][Full Text] [Related]
12. Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients.
Groeneveld PW
LDI Issue Brief; 2008; 13(6):1-4. PubMed ID: 18613344
[TBL] [Abstract][Full Text] [Related]
13. Rules of evidence: CMS and primary prevention of sudden cardiac death in systolic heart failure.
Sweeney MO; Schoenfeld MH; Cannom DS
Pacing Clin Electrophysiol; 2005 Feb; 28(2):81-8. PubMed ID: 15679636
[No Abstract] [Full Text] [Related]
14. Sudden cardiac death risk stratification and assessment: primary prevention based on ejection fraction criteria.
Saba S
Heart Fail Clin; 2011 Apr; 7(2):175-83, vii. PubMed ID: 21439496
[TBL] [Abstract][Full Text] [Related]
15. [Primary prevention of sudden death - afraid of the truth].
Klein H
Dtsch Med Wochenschr; 2002 Oct; 127(41):2113. PubMed ID: 12397556
[No Abstract] [Full Text] [Related]
16. Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria.
Toma M; McAlister FA; Ezekowitz J; Kimber S; Gulamhusein S; Pantano A; Sivakumaran S; Cujec B; Paterson I; Armstrong PW
Am J Cardiol; 2006 Mar; 97(6):882-5. PubMed ID: 16516594
[TBL] [Abstract][Full Text] [Related]
17. Use of a screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.
Gravelin LM; Yuhas J; Remetz M; Radford M; Foley J; Lampert R
Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):152-6. PubMed ID: 21304093
[TBL] [Abstract][Full Text] [Related]
18. Cost of preimplantation cardiac imaging in patients referred for a primary-prevention implantable cardioverter-defibrillator.
Krahn AD; Hoch JS; Rockx MA; Leong-Sit P; Gula LJ; Yee R; Skanes AC; Klein GJ
Am J Cardiol; 2008 Sep; 102(5):588-92. PubMed ID: 18721517
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of the implantable cardiodefibrillator (ICD) in the prevention of sudden death. Results of evidence based medicine].
González CM
Arch Cardiol Mex; 2007; 77 Suppl 2():S2-44-S2-46. PubMed ID: 17972377
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
Ding L; Hua W; Niu H; Chen K; Zhang S
Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
